# Apollo Hospitals Enterprise Limited (APOLLOHOSP)

> APOLLOHOSP closed at ₹8,448.00 on 30 Oct 2026, trailing P/E 58.1, market cap ₹1,21,482 cr, latest results for the quarter ended 30 Jun 2026. Revenue, profit, ROE, debt, own P/E range and sector-peer comparison from the SEBI filing.

Apollo Hospitals Enterprise Limited (NSE: APOLLOHOSP) closed at ₹8,448.00 on 30 Oct 2026, +6.9% over one year, against a 52-week range of ₹6,696.50 – ₹9,070.50.

In the quarter ended 30 Jun 2026 (consolidated, filed 12 Aug 2026) it reported revenue of ₹7,044 cr and net profit of ₹581 cr, a 8.2% net margin; revenue grew 20.6% and profit grew 38.0% year on year.

On four consecutive filed quarters its trailing P/E is 58.1; since 30 May 2025 its own P/E has ranged from 59.0 to 159.3 (median 110.2), and today's reading is higher than 5% of those 350 trading days.

From the balance sheet dated 31 Mar 2026: return on equity 24.5%, ROCE 23.1%, debt-to-equity 0.60, Piotroski F-score 8 of 9.

Against 65 Healthcare peers on NSE: Net margin higher than 19% of 63 sector peers; PBT margin higher than 18% of 63 sector peers; ROE higher than 86% of 63 sector peers.

## Key figures

| Figure | Value |
|---|---|
| Last close | ₹8,448.00 (30 Oct 2026) |
| Change 1 month / 6 months / 1 year | -5.0% / +9.3% / +6.9% |
| 52-week low – high | ₹6,696.50 – ₹9,070.50 |
| Market capitalisation | ₹1,21,482 cr |
| Trailing P/E | 58.1 |
| Price / book | 12.81 |
| EV / EBITDA | 30.2 |
| Earnings yield | 1.7% |
| TTM EPS | ₹145.31 |
| TTM net profit | ₹2,090 cr |
| Quarter revenue | ₹7,044 cr |
| Quarter net profit | ₹581 cr |
| Net margin | 8.2% |
| Revenue growth (YoY) | +20.6% |
| Profit growth (YoY) | +38.0% |
| Return on equity | 24.5% |
| ROCE | 23.1% |
| Debt / equity | 0.60 |
| Current ratio | 1.06 |
| Free cash flow | ₹894 cr |
| Piotroski F-score | 8 / 9 |
| Average daily turnover (50 days) | ₹312.0 cr |

## Questions

### What is the P/E ratio of Apollo Hospitals Enterprise Limited?

Apollo Hospitals Enterprise Limited's trailing P/E is 58.1, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Jun 2026. Since 30 May 2025 its P/E has ranged 59.0–159.3.

### What were Apollo Hospitals Enterprise Limited's latest quarterly results?

For the quarter ended 30 Jun 2026, Apollo Hospitals Enterprise Limited reported revenue of ₹7,044 cr and net profit of ₹581 cr (consolidated), filed with the exchange on 12 Aug 2026.

### What is Apollo Hospitals Enterprise Limited's ROE?

Return on equity is 24.5% based on the balance sheet dated 31 Mar 2026.

### Does Apollo Hospitals Enterprise Limited have debt?

Debt-to-equity is 0.60 on the balance sheet dated 31 Mar 2026.

### What is APOLLOHOSP's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, APOLLOHOSP traded between ₹6,696.50 and ₹9,070.50.

Sector: [Healthcare](https://trinetra.trade/sectors/healthcare) · Page: https://trinetra.trade/fundamentals/APOLLOHOSP

_TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing._